RhoVac recruits Professor Emeritus Per-Anders Abrahamsson and Professor Klaus Brasso to its scientific advice board
RhoVac AB ("RhoVac") is in the final development phase under its own direction with the clinical BraVac study and it intends to intensify its partnership discussions. Pertaining to this, RhoVac announces the recruitment of two very prominent prostate cancer experts, Professor Emeritus Per-Anders Abrahamsson at Lund University and Professor Klaus Brasso at the University of Copenhagen, to the company's Scientific Advisory Board.Per-Anders-Abrahamsson is former Head of Operations at the Urological Clinic, Skåne University Hospital SUS and Research Group Head at the Faculty of Medicine,